Brief: Procaps Q2 Revenue USD 110 Million
05/09/2023 13:25
Sep 05 (Reuters) - Procaps Q2 adjusted EBITDA USD 20 million. * Q2 gross profit USD 61 million
Recent news on Sofgen Pharma SA
See all newsBrief: Procaps Group Receives Delisting Notice From Nasdaq
Brief: Procaps Group Receives Additional Delinquency Letter
Brief: Procaps Group Announces Key Shareholder And Board Decisions, Committee Restructuring, And Leadership Updates
Brief: Procaps Issues Shareholder Letter Update
Brief: Procaps Issues Shareholder Letter Update